Eleven Biotherapeutics Receives Three Federal Grants to Develop Innovative Protein-Based

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics, a biopharmaceutical company focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics, today announced the receipt of three grants totaling more than $733,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program. The grants are directed towards supporting Eleven Biotherapeutics’ lead protein-based discovery programs.